Prikaz rezultata 1 – 5 od 5 za pretragu 'Vibhuti Vyas (15055988)', vrijeme upita: 0,01s Detaljiziraj rezultate
  1. 1
    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  2. 2
    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  3. 3
    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  4. 4
    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  5. 5
    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:

Alati za pretragu: